Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial Assessing Efficacy and Safety of LAS34273 in Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD) Patients

NCT00363896 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00363896
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00363896 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial Assessing Efficacy and Safety of LAS34273 in Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD) Patients
Lead sponsor
AstraZeneca
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2006
Completion date
May 31, 2008
Enrollment
843 (actual)
Sites
132

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease (copd)